Language

About Dow

Dow Biomedica Inc. . is a specialized company in the field of in vitro diagnostics (IVD), serving as a Diagnostics Commercialization Platform Company that integrates innovative technologies into real-world clinical practice.

We go beyond supplying diagnostic products and technologies. Our core capability lies in building and executing an integrated commercialization framework that enables new diagnostic innovations to be effectively adopted in clinical settings. This includes clinical design, market access strategy, and implementation infrastructure.

As healthcare continues to evolve, diagnostics are no longer limited to disease detection. They are becoming essential tools for designing treatment strategies and optimizing patient management pathways. In this changing landscape, the role of a commercialization platform that successfully bridges innovation and clinical adoption is becoming increasingly critical.

At Dow Biomedica, we position ourselves at the center of this transformation. We leverage diagnostics to help design clinical strategies and guide therapeutic decision-making, ensuring that new medical paradigms are effectively translated into clinical practice.

Through this approach, we go beyond being a conventional supplier and take on the role of a Diagnostics Architect—shaping the future of healthcare through the integration of advanced diagnostic technologies.

The D in the Dow logo symbolizes Diagnostics, Dedicated, and DNA.
The blue-green gradation of the logo symbolizes the win-win principle governing the relationship between manufacturers and customers through the circular gradation of the bio platform.

The company name, Dow, when written in Korean (茶友),
can be construed to mean “tea buddies”.
This means that we hope to become a trustworthy friend who shares
emotional connections with our customers and with the market.

Strategic Intent

MISSION

Dow contributes to improving human health through new biomarkers and cutting-edge technology.

VISION

Dow is a leading market developer in the up-and-coming in vitro diagnostic medical device market, delivering enhanced value to both customers and partners.

Key numbers

0

The 1st and the only one product

0

Years history since 2004

0

Millions US$ turnover in 2023

0

Staffs working

Do it Art!

The artistic instincts of DOW-ers, the motivation to utilize technology

Art is often interpreted as an activity that creates beauty.
However, the essence of art actually lies in its mechanism and not in its outcome.

Art is a form of performance where we move our body to express the thoughts and senses in our head to demonstrate it in real life. It is a process of displaying what is unseen, and moving what was stationary.

For this, art is closer to performance rather than explanation, and closer to response from our bodies rather than theories.

  • Do-it-ART
  • Art starts with Spiritedness and Talent
  • The moment where technology is utilized
  • Do-it-ART: The Artistic instincts of Dow-ers
  • The 5 Principle of Do-it-Art
The 5 Principle of Do-it-Art

  • Action before Words

  • Watch the Flow instead of the Product

  • Adjustment rather
    than Perfection

  • We let reality pass through instead of changing the system

  • Results leading
    to Action

F1Dow cafe’ campus | 다우생태계의 기반, 공부하는 분위기의 행복한 캠퍼스

F2Main Conference Room

F3Ware House, Logistics

F4Admin – Finance, Compliance, Logistics, SCM(Supply Chain management), Dow Studio

F5Sales Div. Customer Support, Dow Laboratory

F6Business Development(Scientific Affair), Marketing, CR, RA(Regulatory Affair), FAS(Field Service Specialist), Tribe room(Second conference room)

Location

  • 주소

    서울특별시 송파구 양산로29 다우빌딩 2, 3, 4, 5, 6층

  • 연결

    • 전화+82-2-2201-3602~3
    • 팩스+82-2-2201-2166
    • 이메일contact@dowbiomedica.co.kr

  • 오시는길

    지하철거여역 7번 출구에서 위례동 방향으로 150m (도보 3분)거리

    버스거여역 7번 출구 정류장 (3313번), 거여역 현대아파트 정류장 (3217, 3313, 3318, 3416번)

2021~

  • 2024. 0720th anniversary of incorporation
  • 2023. 11Held the 2023 Vysis User Seminar (SETEC Convention Center, Daechi-dong, Seoul)
  • 2023. 07Received the Binding Site Outstanding Contribution Award 2022 (UK)
  • 2023. 03Received the Illumina Elite Partner Award 2022 (USA)
  • 2022. 10Supplied gastric health serum test diagnostic reagent (GastroPanel from BioHit) to medical check centers
  • 2022. 07Established Healthcare Business Division
  • 2021. 03Appointed first external auditor (to audit 2020) – Disclosed audit report via the Financial Supervisory Service electronic disclosure system

2015~

  • 2020. 11Endocrine hormone and peptide test reagents approved by the Ministry of Food and Drug Safety (GastroPanel - Pepsinogen Ⅰ, etc.)
  • 2020. 05Supplied COVID-19 antigen rapid diagnostic kit (From Celltrion)
  • 2018. 11Concluded molecular product sales agency contract with Abbott, USA
  • 2018. 08Supplied Triage product line from Quidel, USA
  • 2018. 07Established Bio Discovery Co., Ltd., an affiliate company (Incorporated as a separate company)
  • 2016. 11Concluded sales agency agreement for with Illumina, USA to supply NGS reagents and equipment
  • 2016. 08Relocated head office to Dow Building, 29 Yangsan-ro, Songpa-gu, Seoul

2010~

  • 2013. 12Quidel’s Sofia Influenza test reagent certified as “new medical technology” (NECA)
  • 2011. 01Moved offices to 4th Floor, Sejong Building, 115-2 Ogeum-dong, Songpa-gu, Seoul

2004~

  • 2009. 03Multiple myeloma diagnostic reagent Freelite (imported from Binding Site) certified as “new medical technology” (NECA)
  • 2008 .03Supplied companion diagnostic test Vysis FISH (imported from Abbott, USA)
  • 2007 .10Moved offices to 600-2, Jayang 2-dong, Gwangjin-gu, Seoul
  • 2006. 06Incorporated as Dow Biomedica Co., Ltd. (CEO Shin Young-gil)
  • 2004. 07Dow Biomedica founded as sole proprietorship importing medical devices

Sales Status (USG)

7,700,000 USD

8,470,000 USD

24,640,000 USD

40,000,000 USD

  • 2010
  • 2015
  • 2020
  • 2025

Number of employees

14명

22명

40명

52명

  • 2010
  • 2015
  • 2020
  • 2025

Number of Import Licenses for In Vitro Diagnostic Medical Devices

97건

101건

64건

  • CLASS I
  • CLASS II
  • CLASS III

GMP Certifications

GMP총 13개

Do-it-ART

The artistic instincts of DOW-ers, the motivation to utilize technology

Art is often interpreted as an activity that creates beauty.
However, the essence of art actually lies in its mechanism and not in its outcome.

Art is a form of performance where we move our body to express the thoughts and senses in our head to demonstrate it in real life. It is a process of displaying what is unseen, and moving what was stationary.

For this, art is closer to performance rather than explanation, and closer to response from our bodies rather than theories.

Art starts with Spiritedness and Talent

The most common words to describe Koreans are ‘spiritedness’ and ‘talent’. These words may seem like a sentimental expression, However, in real life, they are words that describe the conditions for practice and start of art.

‘Spiritedness’ does not just describe joy. Spiritedness is an internal clash where the body and minds have come together and start to express the energy externally.

Without spiritedness, nothing ever happens. As soon as spiritedness kicks in, the audiences become a part of the performance.

Talent is a skill that manifests on spiritedness. It is an ability of an individual but is never complete itself alone. As soon as spiritedness kicks in to initiate energy, the talent shows which motivates and encourages each other, to expand into a new horizon.

The success of K-pop and K-dramas are an example where this spiritedness and talent has come together structurally to achieve the success, it has today. The most important factor is that this spiritedness and talent does stop in the cultural field.

The moment where technology is utilized

The same phenomenon has been repeatedly seen in the technology and industrial fields.

There are cases where technology is not as utilized abroad, despite its outstanding performances; but is in fact, established quickly and efficiently in Korea and is used as the standard practice in the field. The major examples are R-Mix virus culture counts, Thyretain analysis method, Sofia Influenza A+B Rapid Tests, Next-generation Sequencing (NGS) and LymphoTrack.

The force that takes place is not simply a curiosity of ‘Let’s try this technology since it’s new’. When there is a need to use this newly-introduced technology in the field, the first thing that comes into our mind is the ‘Spiritedness’ of the organization. The willingness to use this technology no matter what and to resolve any issues and problems.

We need the ability to practice this ‘spiritedness’ in real life.

Do-it-ART: The Artistic instincts of Dow-ers

The goal of DOW has been to work towards utilizing the technology and not just simply explaining the technology.

Rather than simply adopting the technology according to its manual, DOW has been working towards in rearranging the sequences accordingly to the field. DOW restructures in a way that reduces burden and to ensure that appropriate actions are triggered to move onto the next step.

This process is extremely artistic. There is no answer set in place but to assess the realistic response and to continue adjusting the process persistently. We call this process Do-it-ART.

Do-it-ART is the artistic instinct of DOW-ers who first performs the technology in which they understand with their logic and to adjust the process right there at the field, making it essential to be used.

The 5 Principle of Do-it-Art
  1. Action before Words Before enforcing the understanding of the process, It is important to encourage the users to experience it first.
  2. Watch the Flow instead of the Product Design and place importance on the when, who and what context it is to be used instead of concentrating on what products to sell.
  3. Adjustment rather than Perfection We take immediate action to tune and adjust rather than aiming for perfection from the very start.
  4. We let reality pass through instead of changing the system Rather than overturning the system, we ensure to work between the regime and practices to make it work.
  5. Results leading to Action We ensure that the results of tests and analysis naturally lead to the next step in decision-making.
Conclusion

Do-it-ART is not a new motto.

It is a way that DOW has been performing work for a long time. We move with our spiritedness; we make adjustments with our talent. We named such artistic instinct of DOW-ers as Do-it-ART who made it possible for technology to come alive and thrive in real life.

We do not create technology. Instead, we ensure that technology evolves.

Art does not give you answers. Instead, they give you questions.

That is Do-it-ART and The way DOW works.